2Suppliers
0Customers
3Debt Items
20Related Chains

Celcuity Inc. Suppliers

TickerNameConfidenceEvidence
PFE Pfizer Inc. 92% The Company entered into a license agreement with Pfizer to research, develop, manufacture and commercialize gedatolisib.
PFE Pfizer Inc. 92% Reciprocal relationship from PFE graph: Reciprocal relationship from CELC graph: Reciprocal relationship from PFE graph: Reciprocal relationship from CELC graph: Reciprocal relationship from PFE grap…

Celcuity Inc. Customers

No clients on recordNo downstream customers found in our database for Celcuity Inc..

Celcuity Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
CELC-DEBT-8579 Xbrl Convertible 90% xbrl convertible detail from xbrl 2025-12-31.
CELC-DEBT-8578 Warrants outstanding: 1827357 90% xbrl warrant detail from xbrl 2025-12-31.
CELC-DEBT Debt stack $323.4M 90% Market cache reports total debt of $323.4M.

Celcuity Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Celcuity Inc..

Celcuity Inc. Ownership

HolderNameConfidenceEvidence
CELC-OWNER-BAKER-BROS-ADVISORS-LP BAKER BROS. ADVISORS LP 90% 13F overlay lists BAKER BROS. ADVISORS LP as top holder; 281 tracked holders.

Celcuity Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
PFE Pfizer Inc. 100.00 1 ['supplier']
CTMX CytomX Therapeutics, Inc. 50.00 2
CELG-RI BRISTOL MYERS SQUIBB CO 50.00 2
ORANY ORANGE 50.00 2
ALLO Allogene Therapeutics, Inc. 50.00 2
CAH Cardinal Health, Inc. 50.00 2
ARVN Arvinas, Inc. 50.00 2
RLAY Relay Therapeutics, Inc. 50.00 2
SPRO Spero Therapeutics, Inc. 50.00 2
HBIO Harvard Bioscience, Inc. 50.00 2
ESPR Esperion Therapeutics, Inc. 50.00 2
NVAX Novavax, Inc. 50.00 2
NRIX Nurix Therapeutics, Inc. 50.00 2
ITRM Iterum Therapeutics PLC 50.00 2
PYXS Pyxis Oncology, Inc. 50.00 2
OPK OPKO Health, Inc. 50.00 2
PLX Protalix BioTherapeutics, Inc. 50.00 2
ZLAB Zai Lab Limited 50.00 2
ZNTL Zentalis Pharmaceuticals, Inc. 50.00 2
AURX Nuo Therapeutics, Inc. 50.00 2